MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹555 Cr | ₹708 Cr | ₹453 Cr | ₹406 Cr | ₹701 Cr |
What is the latest Cash and Bank ratio of MANKIND PHARMA ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹555 Cr |
| Mar2024 | ₹708 Cr |
| Mar2023 | ₹453 Cr |
| Mar2022 | ₹406 Cr |
| Mar2021 | ₹701 Cr |
How is Cash and Bank of MANKIND PHARMA Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹555 Cr | -21.69 | |
| Mar2024 | ₹708 Cr | 56.24 | |
| Mar2023 | ₹453 Cr | 11.64 | |
| Mar2022 | ₹406 Cr | -42.07 | |
| Mar2021 | ₹701 Cr | - | |
Compare Cash and Bank of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹90,805.7 Cr | 0.3% | 2.4% | -22.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 0.3% |
2.4% |
-22.7% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses